StrokeEarly Phase 1REWIRENCT02192125
REWIRE - Rehabilitative Wayout In Responsive Home Environments, A Pilot Trial
A Early Phase 1 study testing REWIRE-System in people with Stroke, run by University of Zurich at 1 site in Switzerland.
Trial summary
The study examines the possible application of the rehabilitation platform REWIRE. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Stroke
- What is being tested?
- REWIRE-System
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 17 participants
- Where
- 1 siteSwitzerland
- Study dates
- Jan 2014to Jul 2015
- Phase
- Early Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age ≥ 18 years
- First-time ischemic stroke
- Moderate, residual motor deficits of the lower extremity (FAC> 3, 6-min walk ≥ 200 m; Berg Balance Scale 21-52)
- Ability and willing to participate in the study
- signed consent form
Who cannot join
- Other neurological disorders (eg Parkinson's disease, dementia, multiple sclerosis, peripheral nerve damage, etc.)
- Moderate to severe aphasia
- moderate to severe unilateral neglect
- Severe dementia, MMSE ≤ 20 points
- Severe depression or psychiatric disorders
- Other serious diseases, such as severe kidney or liver dysfunction, or serious dysfunction of the cardiovascular system
Show all 9Show fewer
- Relevant loss of vision that can not be compensated by aids, eg Hemianopia, visual acuity ≤ 20%
- Severe pain,> 6 points on the visual analog scale
- Pregnancy
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Phase 1 REWIRE - Rehabilitative Wayout In Responsive Home Environments, A Pilot Trial
The study examines the possible application of the rehabilitation platform REWIRE.
Read the detailed description
The REWIRE rehabilitation platform consists of three hierarchical components: the "Patient Station" (PS), which is installed in the home environment of the patient; the "Hospital Station" (HS), which allows an exchange of information with more horsepower and is served by the therapists in the hospital; and the "Networking Station" (NS), which allows a combination of a plurality of HS.
The PS consists of a standard laptop with a specifically created for the rehabilitation REWIRE platform and pre-installed software (Università degli Studi di Milano, Italy, Applied Intelligent Systems Laboratory Department of Computer Science). In the context of a training system connected to the computer, the software enables the collection of data, which are recorded as part of the training. In this study only exercises for balance ability are part of the training program. The training system consists of a so-called Tymoplate® (Tyromotion, Austria), a medical device class 1 with CE certification and approval by the FDA for use in neurorehabilitation after stroke. The Tymoplate® is connected to the computer and allows by means of a base plate with integrated pressure sensors and custom-developed training software, various postural biofeedback exercises. In combination with 3D cameras (Kinect®, PrimeSense, CA, USA), the patient sees him-/herself or an avatar in real time on a screen which moves in the virtual training environment. By various, attractive and entertaining designed training games as well as provided audio-visual feedback and balanced score system, patients should be maximum motivated to exercise.
The HS enables the interaction between patient and therapist and essentially consists of a MySQL database with web-based interface. The data collected on each PS can be retrieved from the HS and can be used by therapists in order to set up the training program on the PS to control and to adjust the difficulty level of the exercises to the individual performance of each patient.
The NS also consists of a database. It links collected training data and the associated epidemiological data of different HS at the regional level (potentially also between different health institutions) to identify on the application of statistical algorithms general models for the description of relaxation processes in rehabilitation medicine.
In this simple way a frequent and intensive training is without direct therapeutic help in the home setting at low cost possible. By attractive and entertaining designed training games as well as interaction and feedback by the therapist, patients are motivated to train each day with the system and to continually improve in the games. The supervision of the training by the therapist with the rehabilitation platform REWIRE additionally serves to recognize improvements of the individual performance or problems and to adapt the difficulty level of the exercises.
For Patient Registries
- Patient recruitment Suitable stationed patients at Cereneo in Vitznau will be informed about the possibility of participation in the study. If interested, the patients will receive the patient information and can decide within a week whether they will participate in the study.
- Data collection We will collect data on daily usage of the patient as well as hospital stations. Patient usage will be regressed on the patient's deficit severity, age and gender to gather preliminary knowledge on whether certain subgroups of patients accept the system better than others.
System usability During and after the pilot trial all involved physicians and physical therapists will answer a standardised questionnaire on system usability. Specifically we will look at the number of instructions and therapy modifications given to the patient and whether the therapist giving the instruction thinks that the patient has reacted accordingly. REWIRE will be also evaluated, in terms of usability of software instruments, degree of control of the rehabilitation process and value of the results reported by REWIRE.
- Data management The investigators will use paper case report forms (CRF), one for each enrolled study participant, to be filled in with all relevant data pertaining to the subject during the study. The investigator will document the participation of each study subject on the enrolment log.
All requested information in the CRF should be completed in a neat legible manner. Use of a black ball pen is recommended to ensure clarity of reproduced copies in the CRF. All corrections in a paper CRF must be made in a way that does not obscure the original entry. The correct data must be inserted, dated and initialled by the investigator Data that are not available or not done should be made clear by adding NA or ND. A declaration ensuring accuracy of data recorded in the case report forms must be signed by the investigator.
CRFs will be kept current to reflect subject status at each phase during the course of study. Subjects will not to be identified in the CRF by name. Appropriate coded identification (e.g. subject number) will be used.
It will be assured that any authorised person, who may perform data entries and changes in the CRF, can be identified. A list with signatures and initials of all authorised persons will be filed in the study site file and the trial master file, respectively.
Documented medical histories and narrative statements relative to the subject's progress during the study will be maintained. These records will also include the following: originals or copies of laboratory and other medical test results which must be kept on file with the individual subject's CRF.
The CIP will specify what will be maintained for each subject. The investigators assure to perform a complete and accurate documentation of the subject data in the CRF. All data entered into the CRF with exception of (for which data the CRF will be source data to be specified for each study) must also be available in the individual subject file either as print-outs or as notes taken by either the investigator or another responsible person assigned by the investigator.
Data which is not included in the CRF will be stored in a secured access database.
Essential documents must be retained for at least 10 years after the regular end or a premature termination of the respective study (VKlin Art. 25). Essential documents will be retained according to local law in case of international multicentre studies.
Any patient files and source data must be archived for the longest possible period of time according to the feasibility of the investigational site, institution or private practice.
- Reporting for adverse events Adverse events will be reported to the Ethics Committee northwest/ central Switzerland EKNZ.
- Change management Sample size assessment to specify the number of participants or participant years necessary to demonstrate an effect Number of patients: 15 stroke patients. Due to the likely large heterogeneity of the study population (different weights severity of paresis and ataxia, as well as partly cognitive deficits) a sufficiently large number of patients must be tested. Currently, there are no data which would allow a power analysis with respect to the primary or secondary end point. In case of premature withdrawl from the study, those participants will be replaced so that at least 16 participants carry out the 3-month training program completely.
Plan for missing data to address situations where variables are reported as missing, unavailable, "non-reported," uninterpretable, or considered missing because of data inconsistency or out-of-range results If in individual clinical tests the data is missing, the concerning test cannot be analysed and will not be considered.
Statistical analysis plan describing the analytical principles and statistical techniques to be employed in order to address the primary and secondary objectives, as specified in the study protocol or plan Primarily, the feasibility of the technical and practical implementation of the rehabilitation REWIRE platform will be evaluated in the home-environment of the study participants. Furthermore, the satisfaction and patient compliance and acceptance of the system by the attending physicians and therapists will be measured. Therefore, structured-standardized questionnaires are used and the quality (if numerically tangible) will be evaluated by means of Likert scales. Secondary, the effects to use the training system on the functional recovery and quality of life as well as on the structural plasticity of the brain will be evaluated. In terms of functional recovery and quality of life correlation analyses will be performed. Related data from stroke patients (from the stroke registry ZORRO, KEK-ZH-E-08/2009) will be compared with those from the REWIRE-study. The evaluation of the data measured by means of magnetic resonance imaging, require before carrying out a correlation analysis the application of parametric statistical methods.
- Conditions
- Stroke
- Being tested
- REWIRE-System
- Keywords
- stroke, rehabilitation, balance, training, posture
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
REWIRE-SystemDevice
Also called Tymoplate®, Kinect®
The REWIRE rehabilitation platform consists of three hierarchical components:
- "patient station" (PS), which is installed in the home environment of the patient: Includes: Laptop with software - Game Tymoplate® - balanceboard Kinect® - 3D tracking
- "Hospital Station" (HS), which allows an exchange of information with more "patient station" and is served by the therapists in the hospital; Includes: Laptop MySQL- database
- "station networking" (NS), which allows a combination of a several of HS. database
| Study group | Role | What they receive |
|---|---|---|
| REWIRE-System | Experimental | The training system consists of a so-called Tymoplate® (Tyromotion, Austria), a medical device class 1 with CE certification and approval by the FDA for use in neurorehabilitation after stroke. The Tymoplate® is connected to a computer and allows by means of a base plate with integrated pressure sensors and custom-developed training software different postural biofeedback exercise. Receives: Device: REWIRE-System |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proof of concept
Technical and practical implementation of the rehabilitation platform REWIRE will be evaluated, by a questionnaire.
Measured: week 12
Secondary outcomes (1)
Quality of life
Assessments, change from Baseline :
- Stroke Impact Scale
- EuroQol
- FES-I (Erfassung der sturzassoziierten Selbstwirksamkeit, 10 min)
- Technology Acceptance Model / TAM
Measured: week 12
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jul 2014 (estimated)
- Study startJan 2014
- Primary completionJul 2015
- Study completionJul 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- More trials run by University of ZurichThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Early Phase 1
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 17 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Zurich
- Sponsor type
- University, hospital or other
- Collaborators
- University of Milan, Ecole Polytechnique Fédérale de Lausanne, University of Oxford, University of Padova, Swiss Federal Institute of Technology, Ab.Acus Srl, Fundación Pública Andaluza Progreso y Salud, Technogym SpA, Fundació Privada Barcelona Digital Centre Tecnològic (BDIGITAL), University Hospital, Zürich, JSI Research & Training Institute, Inc., Hospitales Universitarios Virgen del Rocío
- Responsible party
- Sponsor
- Investigators
- Andrea R Luft, Prof., Principal investigator, University of Zurich
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02192125
- Sponsor's protocol ID
- 2014-061
- Acronym
- REWIRE
- Status last verified
- May 2015
- First submitted
- 30 May 2014
- Last updated
- 15 Sep 2015
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Sep 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Phase 1 REWIRE - Rehabilitative Wayout In Responsive Home Environments, A Pilot Trial
- ClinicalTrials.gov ID
- NCT02192125
- Acronym / sponsor ID
- REWIRE / 2014-061
- Conditions
- Stroke
- Keywords
- stroke, rehabilitation, balance, training, posture
- Phase
- Early Phase 1
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 17 participants (actual)
- Lead sponsor
- University of ZurichUniversity, hospital or other
- Collaborators
- University of Milan, Ecole Polytechnique Fédérale de Lausanne, University of Oxford, University of Padova, Swiss Federal Institute of Technology, Ab.Acus Srl, Fundación Pública Andaluza Progreso y Salud, Technogym SpA, Fundació Privada Barcelona Digital Centre Tecnològic (BDIGITAL), University Hospital, Zürich, JSI Research & Training Institute, Inc., Hospitales Universitarios Virgen del Rocío
- Study start
- Jan 2014
- Primary completion
- Jul 2015 (actual)
- Study completion
- Jul 2015 (actual)
- First posted
- 16 Jul 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study examines the possible application of the rehabilitation platform REWIRE.
Detailed description
The REWIRE rehabilitation platform consists of three hierarchical components: the "Patient Station" (PS), which is installed in the home environment of the patient; the "Hospital Station" (HS), which allows an exchange of information with more horsepower and is served by the therapists in the hospital; and the "Networking Station" (NS), which allows a combination of a plurality of HS.
The PS consists of a standard laptop with a specifically created for the rehabilitation REWIRE platform and pre-installed software (Università degli Studi di Milano, Italy, Applied Intelligent Systems Laboratory Department of Computer Science). In the context of a training system connected to the computer, the software enables the collection of data, which are recorded as part of the training. In this study only exercises for balance ability are part of the training program. The training system consists of a so-called Tymoplate® (Tyromotion, Austria), a medical device class 1 with CE certification and approval by the FDA for use in neurorehabilitation after stroke. The Tymoplate® is connected to the computer and allows by means of a base plate with integrated pressure sensors and custom-developed training software, various postural biofeedback exercises. In combination with 3D cameras (Kinect®, PrimeSense, CA, USA), the patient sees him-/herself or an avatar in real time on a screen which moves in the virtual training environment. By various, attractive and entertaining designed training games as well as provided audio-visual feedback and balanced score system, patients should be maximum motivated to exercise.
The HS enables the interaction between patient and therapist and essentially consists of a MySQL database with web-based interface. The data collected on each PS can be retrieved from the HS and can be used by therapists in order to set up the training program on the PS to control and to adjust the difficulty level of the exercises to the individual performance of each patient.
The NS also consists of a database. It links collected training data and the associated epidemiological data of different HS at the regional level (potentially also between different health institutions) to identify on the application of statistical algorithms general models for the description of relaxation processes in rehabilitation medicine.
In this simple way a frequent and intensive training is without direct therapeutic help in the home setting at low cost possible. By attractive and entertaining designed training games as well as interaction and feedback by the therapist, patients are motivated to train each day with the system and to continually improve in the games. The supervision of the training by the therapist with the rehabilitation platform REWIRE additionally serves to recognize improvements of the individual performance or problems and to adapt the difficulty level of the exercises.
For Patient Registries
- Patient recruitment Suitable stationed patients at Cereneo in Vitznau will be informed about the possibility of participation in the study. If interested, the patients will receive the patient information and can decide within a week whether they will participate in the study.
- Data collection We will collect data on daily usage of the patient as well as hospital stations. Patient usage will be regressed on the patient's deficit severity, age and gender to gather preliminary knowledge on whether certain subgroups of patients accept the system better than others.
System usability During and after the pilot trial all involved physicians and physical therapists will answer a standardised questionnaire on system usability. Specifically we will look at the number of instructions and therapy modifications given to the patient and whether the therapist giving the instruction thinks that the patient has reacted accordingly. REWIRE will be also evaluated, in terms of usability of software instruments, degree of control of the rehabilitation process and value of the results reported by REWIRE.
- Data management The investigators will use paper case report forms (CRF), one for each enrolled study participant, to be filled in with all relevant data pertaining to the subject during the study. The investigator will document the participation of each study subject on the enrolment log.
All requested information in the CRF should be completed in a neat legible manner. Use of a black ball pen is recommended to ensure clarity of reproduced copies in the CRF. All corrections in a paper CRF must be made in a way that does not obscure the original entry. The correct data must be inserted, dated and initialled by the investigator Data that are not available or not done should be made clear by adding NA or ND. A declaration ensuring accuracy of data recorded in the case report forms must be signed by the investigator.
CRFs will be kept current to reflect subject status at each phase during the course of study. Subjects will not to be identified in the CRF by name. Appropriate coded identification (e.g. subject number) will be used.
It will be assured that any authorised person, who may perform data entries and changes in the CRF, can be identified. A list with signatures and initials of all authorised persons will be filed in the study site file and the trial master file, respectively.
Documented medical histories and narrative statements relative to the subject's progress during the study will be maintained. These records will also include the following: originals or copies of laboratory and other medical test results which must be kept on file with the individual subject's CRF.
The CIP will specify what will be maintained for each subject. The investigators assure to perform a complete and accurate documentation of the subject data in the CRF. All data entered into the CRF with exception of (for which data the CRF will be source data to be specified for each study) must also be available in the individual subject file either as print-outs or as notes taken by either the investigator or another responsible person assigned by the investigator.
Data which is not included in the CRF will be stored in a secured access database.
Essential documents must be retained for at least 10 years after the regular end or a premature termination of the respective study (VKlin Art. 25). Essential documents will be retained according to local law in case of international multicentre studies.
Any patient files and source data must be archived for the longest possible period of time according to the feasibility of the investigational site, institution or private practice.
- Reporting for adverse events Adverse events will be reported to the Ethics Committee northwest/ central Switzerland EKNZ.
- Change management Sample size assessment to specify the number of participants or participant years necessary to demonstrate an effect Number of patients: 15 stroke patients. Due to the likely large heterogeneity of the study population (different weights severity of paresis and ataxia, as well as partly cognitive deficits) a sufficiently large number of patients must be tested. Currently, there are no data which would allow a power analysis with respect to the primary or secondary end point. In case of premature withdrawl from the study, those participants will be replaced so that at least 16 participants carry out the 3-month training program completely.
Plan for missing data to address situations where variables are reported as missing, unavailable, "non-reported," uninterpretable, or considered missing because of data inconsistency or out-of-range results If in individual clinical tests the data is missing, the concerning test cannot be analysed and will not be considered.
Statistical analysis plan describing the analytical principles and statistical techniques to be employed in order to address the primary and secondary objectives, as specified in the study protocol or plan Primarily, the feasibility of the technical and practical implementation of the rehabilitation REWIRE platform will be evaluated in the home-environment of the study participants. Furthermore, the satisfaction and patient compliance and acceptance of the system by the attending physicians and therapists will be measured. Therefore, structured-standardized questionnaires are used and the quality (if numerically tangible) will be evaluated by means of Likert scales. Secondary, the effects to use the training system on the functional recovery and quality of life as well as on the structural plasticity of the brain will be evaluated. In terms of functional recovery and quality of life correlation analyses will be performed. Related data from stroke patients (from the stroke registry ZORRO, KEK-ZH-E-08/2009) will be compared with those from the REWIRE-study. The evaluation of the data measured by means of magnetic resonance imaging, require before carrying out a correlation analysis the application of parametric statistical methods.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| REWIRE-System | Experimental | Device: REWIRE-SystemThe training system consists of a so-called Tymoplate® (Tyromotion, Austria), a medical device class 1 with CE certification and approval by the FDA for use in neurorehabilitation after stroke. The Tymoplate® is connected to a computer and allows by means of a base plate with integrated pressure sensors and custom-developed training software different postural biofeedback exercise. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Age ≥ 18 years
- First-time ischemic stroke
- Moderate, residual motor deficits of the lower extremity (FAC> 3, 6-min walk ≥ 200 m; Berg Balance Scale 21-52)
- Ability and willing to participate in the study
- signed consent form
Key exclusion criteria (9 listed)
- Other neurological disorders (eg Parkinson's disease, dementia, multiple sclerosis, peripheral nerve damage, etc.)
- Moderate to severe aphasia
- moderate to severe unilateral neglect
- Severe dementia, MMSE ≤ 20 points
- Severe depression or psychiatric disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| REWIRE-SystemAlso: Tymoplate®, Kinect®The REWIRE rehabilitation platform consists of three hierarchical components: 1. "patient station" (PS), which is installed in the home environment of the patient: Includes: Laptop with software - Game Tymoplate® - balanceboard Kinect® - 3D tracking 2. "Hospital Station" (HS), which allows an exchange of information with more "patient station" and is served by the therapists in the hospital; Includes: Laptop MySQL- database 3. "station networking" (NS), which allows a combination of a several of HS. database | Device | REWIRE-System |
Primary outcome
Proof of concept
Time frame: week 12
Technical and practical implementation of the rehabilitation platform REWIRE will be evaluated, by a questionnaire.
1 secondary outcome
Quality of life
Time frame: week 12
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Sep 2015.
- REWIRE is a European Project funded by the Seventh Framework Program, that develops, integrates and field tests an innovative virtual reality based rehabilitation platform system based on a multi-level rehabilitation platformLink provided by the sponsor.
Related trials for Stroke
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
RecruitingObservational study
ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window
Acute Ichemic Stroke
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Aneurysm Hemorrhage
Not yet recruiting
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Acute Ischemic Stroke, Basilar Artery Occlusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Andrea R Luft, Prof. principal investigator
University of Zurich
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Early Phase 1 study testing REWIRE-System in people with Stroke, run by University of Zurich at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Sep 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proof of concept (time frame: week 12). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2015; AzTrials last refreshed its copy on 7 Nov 2026.